Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.01 (+0.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Non Operating Income (2019 - 2026)

Updated

Black Diamond Therapeutics (BDTX) posted Non Operating Income of $2.15 million for Q2 2026, down 24.7% from $2.86 million a year earlier and down 3.2% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Non Operating Income (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Black Diamond Therapeutics was $9.35 million, down 4.0% year-over-year; for FY2025, it came in at $9.85 million, up 8.1% from FY2024.

  • Annual Non Operating Income has increased for four consecutive years, with a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
  • In prior years, Black Diamond Therapeutics' Non Operating Income was $9.11 million in FY2024 (+126.6%), $4.02 million in FY2023 (+2.8%), $3.91 million in FY2022 (+206.3%) and $1.28 million in FY2021 (-44.9%).
  • The Q2 2026 figure stands as the lowest quarterly Non Operating Income since Q1 2025.
  • On a year-over-year basis, Non Operating Income increased in five of the last eight quarters, with growth averaging 29.2%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q1 2023, with growth of 298.8%; the weakest was Q4 2021, with a decline of 61.8%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $2.22 million (Q1 2026), $2.49 million (Q4 2025) and $2.48 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 387.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Black Diamond Therapeutics 118.75 Mn -374.17 Mn - 2.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.15 Mn
Mar 31, 2026 2.22 Mn
Dec 31, 2025 2.49 Mn
Sep 30, 2025 2.48 Mn
Jun 30, 2025 2.86 Mn
Mar 31, 2025 2.01 Mn
Dec 31, 2024 2.29 Mn
Sep 30, 2024 2.57 Mn
Jun 30, 2024 2.22 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 1.45 Mn
Sep 30, 2023 1.01 Mn
Jun 30, 2023 880,000.00
Mar 31, 2023 686,000.00
Dec 31, 2022 3.02 Mn
Sep 30, 2022 470,000.00
Jun 30, 2022 243,000.00
Mar 31, 2022 172,000.00
Dec 31, 2021 213,000.00
Sep 30, 2021 287,000.00
API Access

Black Diamond Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=BDTX&period=max&api_key=YOUR_API_KEY